Industry Explorers Blaze On

  1. How Do Outsourcers Feel About The CDMO Industry? 10/2/2023

    Now is the time for company leaders at all stages to evaluate insurance costs, which can be among the top five most significant budget line items.

  2. Safeguarding Biopharmas From Product Shortages 10/2/2023

    The COVID-19 pandemic is just one example of the types of supply chain disruptions that life sciences companies faced. It is important to understand there are key considerations that can help life sciences businesses prepare for and respond to product shortages.

  3. The Role Of Leadership In Change Management 10/2/2023

    Leadership is the cause of effective change management. As catalysts of change, leaders are responsible for steering their organizations through the often-tumultuous journey of transformation. Their approach, communication, and actions can increase the acceptance and success of change initiatives within the organization.

  4. Sterile Injectable Life Cycle Management 10/2/2023

    In a recent study on the market outlook for sterile injectable drug product manufacturing, ISR asked respondents whether their company is investigating improving or extending the life cycle of sterile injectable drug products in their portfolio.

  5. Leading A Successful Back Office Transformation 10/2/2023

    This article will lay out the types of events that should trigger additional investment in back office systems along with key decisions to help ensure a successful project.

  6. I Could've Used A Mentorship Group … So I Created One 10/2/2023

    Carolina Serrano Martinez realized that she could leverage her experience to build something that would create opportunities for those that looked like her, and those who didn’t.

  7. Life Biosciences Grows Up: A Q&A With Jerry McLaughlin 10/2/2023

    Through the boom and bust of anti-aging buzz cycles, Life Biosciences has continued its focus on epigenetic reprogramming with an increasingly focused pipeline and development strategy.

  8. Companies To Watch: Spruce Biosciences 10/2/2023

    Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.

  9. Leadership Pressures: Causing An Imbalanced Organization 9/1/2023

    We all must do what’s best for our business, our teams (people), and ultimately the patient in a compliant manner. So, what happens if you prioritize one over the other?

  10. Biotech Needs To Pay More Attention To Data-Privacy Laws 9/1/2023

    Biotech professionals are already familiar with the complex regulatory environment surrounding healthcare, medical innovations, and clinical trials, and have developed departments, policies and procedures to comply with them. Yet like many other industries, the biotech industry is playing catch-up when it comes to constantly expanding global privacy regulations.